Recently, a new lncRNA, HIF1A-AS2, was found to be dysregulated in several tumors, such as colorectal cancer, breast cancer, glioblastoma, bladder cancer and gastric cancer [31–35]. This evidence concerns the gene HIF1A and urinary bladder carcinoma.